dodecyl-beta-d-maltoside has been researched along with Multiple Sclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dike, S; Kerr, DA; Levy, M; Maggio, ET; Rifkin, RA | 1 |
1 other study(ies) available for dodecyl-beta-d-maltoside and Multiple Sclerosis
| Article | Year |
|---|---|
n-Dodecyl-β-D-maltoside inhibits aggregation of human interferon-β-1b and reduces its immunogenicity.
Topics: Animals; Antibodies, Neutralizing; Antibody Formation; Detergents; Enzyme-Linked Immunosorbent Assay; Excipients; Female; Glucosides; Humans; Interferon beta-1b; Interferon-beta; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Neopterin | 2011 |